Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07089576 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
A NA study of Aortic Arch Aneurysm and Aortic Arch Dissection, sponsored by Artivion.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 10
- Study locations
NCT07089576 is a NA study of Aortic Arch Aneurysm and Aortic Arch Dissection that is actively recruiting participants, run by Artivion. The registered enrollment target is 132 participants, below the 501-participant average among 4 other Aortic Arch Aneurysm trials with a reported enrollment target (74% lower). The trial reports 10 study locations across 8 states.
The verdict
NCT07089576, a NA study of Aortic Arch Aneurysm and Aortic Arch Dissection, is actively recruiting participants, sponsored by Artivion.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Conditions Studied
Interventions
- DEVICE Arcevo™ LSA Hybrid Stent Graft System
Study Locations (10)
New York
- Columbia University Irving Medical Center/New York Presbyterian Hospital - New York
- Montefiore Medical Center - The Bronx
Texas
- University of Texas - Austin - Austin
- Baylor Scott & White - Plano
California
- University of Southern California - Los Angeles
Georgia
- Emory University School of Medicine - Atlanta
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Maryland
- Johns Hopkins Hospital - Baltimore
Ohio
- Cleveland Clinic Foundation - Cleveland
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2025-11-04 |
| Est. Completion | 2032-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07089576
The ClinicalTrials.gov registry entry for NCT07089576 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 501-participant average among 4 other Aortic Arch Aneurysm trials with a reported enrollment target (74% lower). The listed sponsor is Artivion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aortic Arch Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Arcevo™ LSA Hybrid Stent Graft System is the first listed.
NCT07089576 reports 10 study locations spanning 8 distinct geographic areas - top geographies include New York, Texas, California.
Frequently Asked Questions
What is clinical trial NCT07089576 about?
NCT07089576 is a clinical study titled "Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA". The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
What is the current status of trial NCT07089576?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2025-11-04. Estimated completion is 2032-07.
What conditions does trial NCT07089576 study?
This clinical trial studies the following conditions: Aortic Arch Aneurysm, Aortic Arch Dissection, Acute Aortic Dissection, Chronic Aortic Dissection.
What interventions are being tested in trial NCT07089576?
The interventions under investigation include: Arcevo™ LSA Hybrid Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT07089576?
This trial is sponsored by Artivion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07089576 being conducted?
This trial has 10 study locations across California, Georgia, Illinois, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Arch Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
RECRUITING · NA
-
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.